Sponsor · clinical trials

Medacta International clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our France, Switzerland, Italy, UK, Austria, Australia, Belgium and Germany registers with Medacta International as lead sponsor. Synced 11 Nov 2026

28Current trials

13Recruiting now

0Drugs in these trials

8Trial registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 11 Nov 2026 · Editorial standards

At a glance

Medacta International is the lead sponsor of 28 current clinical trials in our France, Switzerland, Italy, UK, Austria, Australia, Belgium and Germany registers. 13 are recruiting patients now. The most common phase is Observational. The most-studied condition is Traumatic Arthritis.

ClinicalTrials.gov trials by status

Recruiting1346%
Active, closed1554%

Trials by phase

Observational2382%
Not applicable518%

Clinical trials sponsored by Medacta International

28 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
The Medacta International SMS Post-Marketing Surveillance Study NCT02748408 · Arthrosis, Traumatic Arthritis, Rheumatoid Polyarthritis	Observational	Recruiting	2015-07	UK, Italy, Switzerland, Austria
The Medacta GMK SpheriKA Post-Marketing Surveillance Study NCT05459948 · ClinicalTrials.gov ↗ · Arthropathy, Knee Replacement	Observational	Recruiting	2022-07	France, Italy, Switzerland
Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty NCT05679232 · ClinicalTrials.gov ↗ · Arthritis, Traumatic Arthritis, Avascular Necrosis	Not applicable	Recruiting	2022-12	Austria
A Post Market Surveillance Study About the MONOCER Cup NCT05785364 · ClinicalTrials.gov ↗ · Total Hip Arthroplasty	Observational	Recruiting	2022-01	Switzerland
Clinical and Radiological Outcomes of Medacta Shoulder System FR NCT05926622 · ClinicalTrials.gov ↗ · Primary Osteoarthritis, Secondary Osteoarthritis, Rotator Cuff Tear Arthropathy	Observational	Recruiting	2022-03	France
M-ARS ACL Post-marketing Surveillance Study NCT04462458 · ClinicalTrials.gov ↗ · Anterior Cruciate Ligament (ACL) Reconstruction	Observational	Recruiting	2022-07	Germany, Austria
Clinical Utility and Gait Analysis of NextAR System AUS NCT05863741 · ClinicalTrials.gov ↗ · Total Knee Arthroplasty	Observational	Recruiting	2022-05	Australia
Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System NCT06775704 · ClinicalTrials.gov ↗ · Arthritis (Hip), Hip Dysplasia, Congenital	Observational	Recruiting	2025-07	France
Mpact 3D Metal Monolit Study NCT06748885 · ClinicalTrials.gov ↗ · Total Hip Arthroplasty (THA)	Observational	Recruiting	2024-02	France
Multicentre SMS Study - FR NCT06640764 · ClinicalTrials.gov ↗ · Dysplasia of Hip Joint, Hip Osteoarthritis, Traumatic Arthritis of Hip	Observational	Recruiting	2024-09	France
Multicenter Mpact DM France NCT05818891 · ClinicalTrials.gov ↗ · Total Hip Arthroplasty, Survival, Prosthesis	Observational	Recruiting	2018-04	France
GMK Sphere TiNb Total Knee Arthroplasty PMS Study NCT04801654 · ClinicalTrials.gov ↗ · Total Knee Arthroplasty	Observational	Recruiting	2020-02	Italy
Mpact 3D Metal Cup PMS NCT04801680 · ClinicalTrials.gov ↗ · Total Hip Arthroplasty	Observational	Recruiting	2019-11	Italy
The Medacta International GMK Sphere Post-Marketing Surveillance Study NCT02199600 · Arthritis, Traumatic Arthritis, Rheumatoid Arthritis	Not applicable	Active, closed	2012-10	UK, Belgium
AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study NCT01107340 · Osteoarthritis, Arthritis, Avascular Necrosis	Not applicable	Active, closed	2010-01	UK, Switzerland
Mirror Medacta Shoulder System Pivotal Trial NCT05062252 · ClinicalTrials.gov ↗ · Arthritis Shoulder, Post-traumatic Arthrosis of Other Joints, Upper Arm	Not applicable	Active, closed	2022-01	Switzerland
The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study NCT05003414 · ClinicalTrials.gov ↗ · Arthritis, Traumatic Arthritis, Rheumatoid Arthritis	Observational	Active, closed	2020-01	France, Switzerland
Clinical and Radiological Outcomes of Medacta Shoulder System NCT03547947 · ClinicalTrials.gov ↗ · Primary Osteoarthritis, Secondary Osteoarthritis, Rotator Cuff Tear Arthropathy	Observational	Active, closed	2018-06	Germany, France, Switzerland
EBRA Study AMISTEM-C FR NCT05848024 · ClinicalTrials.gov ↗ · Total Hip Arthroplasty	Observational	Active, closed	2017-02	France
RSA Masterloc Study Australia NCT05818878 · ClinicalTrials.gov ↗ · Radiostereometric Analysis	Observational	Active, closed	2020-09	Australia
Clinical and Radiological Outcomes of Medacta Shoulder System (BE) NCT05002335 · ClinicalTrials.gov ↗ · Primary Osteoarthritis, Secondary Osteoarthritis, Rotator Cuff Tear Arthropathy	Observational	Active, closed	2020-10	Belgium
Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay NCT06012656 · ClinicalTrials.gov ↗ · Primary Osteoarthritis, Secondary Osteoarthritis, Traumatic Arthritis	Observational	Active, closed	2019-01	France
Multicentre GMK UNI Anatomical Cementless Study - FR NCT06715917 · ClinicalTrials.gov ↗ · Osteoarthritis of the Knee, Avascular Necrosis of the Femoral Condyle, Revision Surgery	Observational	Active, closed	2017-03	France, Switzerland
GMK-UNI Anatomical UKA: Fixation of Cemented vs Cementless Designs NCT03522025 · ClinicalTrials.gov ↗ · Osteoarthritis, Knee	Not applicable	Active, closed	2019-02	France, Switzerland
Monocer AOANJRR Registry-nested Study NCT05822505 · ClinicalTrials.gov ↗ · Survival, Prosthesis	Observational	Active, closed	2021-01	Australia
Bone Fixation of Mpact Double Mobility Cup NCT02850575 · ClinicalTrials.gov ↗ · Total Hip Replacement	Observational	Active, closed	2014-01	France
The Medacta Quadra-P Anteverted Study NCT05460715 · ClinicalTrials.gov ↗ · Arthrosis, Traumatic Arthritis, Rheumatoid Polyarthritis	Observational	Active, closed	2021-07	Italy
The Medacta International AMIStem-P Post-Marketing Surveillance Study NCT04997005 · ClinicalTrials.gov ↗ · Arthrosis, Traumatic Arthritis, Rheumatoid Polyarthritis	Observational	Active, closed	2019-04	France

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Conditions in Medacta International trials

35 conditions

Traumatic Arthritis7Arthritis4Primary Osteoarthritis4Secondary Osteoarthritis4Total Hip Arthroplasty4Rheumatoid Arthritis3Arthrosis3Rheumatoid Polyarthritis3Congenital Hip Dysplasia3Rotator Cuff Tear Arthropathy3Rheumatoid Arthritis Shoulder3Poly-arthritis2Avascular Necrosis2Survival, Prosthesis2Total Knee Arthroplasty2 Osteoarthritis1Fracture of the Femoral Neck or Head1Anterior Cruciate Ligament (ACL) Reconstruction1Arthropathy1Knee Replacement1Arthritis (Hip)1Hip Dysplasia, Congenital1Total Hip Arthroplasty (THA)1Dysplasia of Hip Joint1

By trial register

Register	Trials	Recruiting
Clinical trials in France	14	6
Clinical trials in Switzerland	9	3
Clinical trials in Italy	5	4
Clinical trials in UK	3	1
Clinical trials in Austria	3	3
Clinical trials in Australia	3	1
Clinical trials in Belgium	2	0
Clinical trials in Germany	2	1

A trial with sites in more than one country appears in each of those registers.

Questions about Medacta International trials

How many clinical trials does Medacta International sponsor?

Medacta International is the lead sponsor of 28 current trials on ClinicalTrials.gov in our France, Switzerland, Italy, UK, Austria, Australia, Belgium and Germany registers, as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.

Are Medacta International trials recruiting?

Yes. 13 of its 28 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.